Administración de hierro intravenoso en la consulta de nefrología
- Ignacio Minguela, José
- Ángeles Moraza, María
- Chena, Alejandro
- Jimeno, Isabel
- Ocharan-Corcuera, Julen
- Ruiz-de-Gauna, Ramón
ISSN: 1886-2845
Year of publication: 2009
Volume: 30
Issue: 1
Pages: 8-10
Type: Article
More publications in: Diálisis y trasplante: publicación oficial de la Sociedad Española de Diálisis y Trasplante
Abstract
Aim The aim of this study was to evaluate the use, safety and efficacy of intravenous iron administration in the nephrology outpatient consulting room in patients not under dialysis. Patients and methods Patients receiving intravenous sucrose iron (Venofer®) in the nephrology outpatient consulting room from January 2006 to March 2008 were included. Demographic data, iron dosages, treatment length and reasons for finishing the treatment were recorded. Results Sixty-three patients were included (2/3 males). A total of 119 dosage schedules were registered (81% of patients had ≤ 2 dosages). The most frequent amounts per dose were one ampoule (66%), two ampoules (33%) and a half ampoule (1%). The frequency of administration ranged between each week and every 4 months, while the most common frequency was monthly. Ferritin levels increased significantly (82.3 ± 83.5 vs. 217 ± 159.7 – paired t-test; p < 0.001). At the end of the study, 28 patients continued to receive the treatment, while 14 had started on dialysis. No serious adverse effects were detected. Conclusion Intravenous iron administration in the nephrology outpatient consulting room is safe and effective.